255 related articles for article (PubMed ID: 31600211)
1. Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer.
Andrade DAP; da Silva VD; Matsushita GM; de Lima MA; Vieira MA; Andrade CEMC; Schmidt RL; Reis RM; Dos Reis R
PLoS One; 2019; 14(10):e0220086. PubMed ID: 31600211
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
3. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB.
Han KH; Kim HS; Lee M; Chung HH; Song YS
Medicine (Baltimore); 2017 May; 96(21):e6976. PubMed ID: 28538399
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of squamous differentiation in endometrioid type endometrial cancer: a matched analysis.
Aslan K; Öz M; Ersak B; Müftüoğlu HK; Moraloğlu Tekin Ö; Meydanli MM
J Obstet Gynaecol; 2022 Apr; 42(3):494-500. PubMed ID: 34155955
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
[TBL] [Abstract][Full Text] [Related]
6. The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.
Yarandi F; Shirali E; Akhavan S; Nili F; Ramhormozian S
Eur J Med Res; 2023 Mar; 28(1):118. PubMed ID: 36915143
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
Weinberg LE; Kunos CA; Zanotti KM
Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting recurrence in patients with stage IA endometrioid endometrial cancer: what is the importance of LVSI?
Ureyen I; Karalok A; Turkmen O; Kimyon G; Akdas YR; Akyol A; Tasci T; Turan T
Arch Gynecol Obstet; 2020 Mar; 301(3):737-744. PubMed ID: 31883046
[TBL] [Abstract][Full Text] [Related]
9. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
[TBL] [Abstract][Full Text] [Related]
11. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
[TBL] [Abstract][Full Text] [Related]
12. Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.
Panggid K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S
J Obstet Gynaecol Res; 2010 Oct; 36(5):1044-8. PubMed ID: 21058438
[TBL] [Abstract][Full Text] [Related]
13. Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma.
Worley MJ; Davis M; Berhie SH; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Campos SM
Gynecol Oncol; 2014 Oct; 135(1):54-7. PubMed ID: 25088333
[TBL] [Abstract][Full Text] [Related]
14. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.
Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262
[TBL] [Abstract][Full Text] [Related]
16. CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
Kurnit KC; Kim GN; Fellman BM; Urbauer DL; Mills GB; Zhang W; Broaddus RR
Mod Pathol; 2017 Jul; 30(7):1032-1041. PubMed ID: 28281553
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer.
Cusano E; Myers V; Samant R; Sudai T; Keller A; Le T; E C; Grimes S; Xu Y
Int J Gynecol Cancer; 2018 Jun; 28(5):890-894. PubMed ID: 29538248
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
[TBL] [Abstract][Full Text] [Related]
19. Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study.
Kwon JS; Carey MS; Cook EF; Qiu F; Paszat L
Int J Gynecol Cancer; 2007; 17(2):433-40. PubMed ID: 17309565
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Site-Specific Tumor Relapses in Patients With Stage I-II Endometrioid Endometrial Cancer.
Tuomi T; Pasanen A; Leminen A; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2017 Jun; 27(5):923-930. PubMed ID: 28498250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]